Eggshell Membrane Powder Market (2026 - 2036)

Eggshell Membrane Powder Market Forecast and Outlook 2026 to 2036

The eggshell membrane powder market is set for strong expansion, advancing at a 13.1% CAGR from USD 2 billion in 2026 to USD 7 billion by 2036. This upward trajectory represents a structural re‑rating of the category, driven by processors increasingly shifting away from traditional commodity‑linked revenue cycles and toward high‑margin applications in the clinical wellness and nutraceutical sectors.

Expansion is anchored in a structural pivot where egg processors like Kewpie and Burnbrae Farms monetize waste streams to offset tightening environmental compliance costs, effectively turning a disposal liability into a billion-dollar profit pool.

Official figures from the USDA NASS report that United States egg production totaled 9.19 billion eggs during October 2024 alone, creating a massive, consistent feedstock volume that incentivizes capital investment in industrial-scale membrane separation facilities. As per FMI's projection, high-throughput breakers will increasingly integrate hydrolysis units directly onsite, reducing logistics expenses and stabilizing supply for large-scale nutraceutical contracts that demand traceability.

Supply chain resilience is now a boardroom priority, as evidenced by major investments in grading and processing infrastructure designed to minimize organic waste.  As per Burnbrae Farms, President & CEO, Burnbrae Farms (May 2025): "In addition, we announced the construction of a state-of-the-art grading facility in Western Ontario, set to open in 2026.

It will incorporate cutting- edge egg grading, automation, food safety, and environmental technologies that advance our vision to be a leader in sustainable egg production, grading, and processing." Such strategic commitment to advanced infrastructure confirms that leading operators are moving beyond simple volume expansion toward technology-led efficiency that maximizes yield per shell.

Summary of Eggshell Membrane Powder Market

• Commercial activity in this sector centers on extracting protein-rich membranes from industrial egg breaking waste for use in dietary supplements, cosmetics, and pet nutrition. Processors are converting disposal costs into revenue by selling hydrolyzed and native membrane powders to formulators who demand natural sources of collagen and glycosaminoglycans.
• FMI taxonomy defines the scope to include all commercially traded membrane formats, such as hydrolyzed, unhydrolyzed, and concentrated powders derived from chicken eggs. The valuation explicitly excludes raw unprocessed eggshells sold as low-grade fertilizer and general calcium carbonate commodities that lack the functional membrane component.
• As per FMI's projection, the sector will expand from USD 2 billion in 2026 to USD 7 billion by 2036, advancing at a CAGR of 13.1%. This forecast utilizes a bottom-up modeling approach based on layer flock sizes, breaking facility throughput rates, and adoption curves for upcycled cosmetic ingredients.
• Operating models are shifting from simple byproduct disposal to integrated biorefinery concepts where yield efficiency is the primary KPI. Data from Japan indicates that eggshell waste volumes exceed 250,000 tons annually, incentivizing processors to install on-site separation technology that captures membrane value before shells are ground for lower-margin applications.
• Biova LLC, Stratum Nutrition, and Eggnovo SL dominate the competitive landscape by holding key process patents that create barriers to entry for generic entrants. These players defend market share through clinical validation of their branded ingredients, making it difficult for commodity egg breakers to compete directly without similar scientific investment.
• Japan represents the fastest-growing territory with an 18.9% CAGR, driven by strict industrial waste mandates and a mature functional food culture. The United Kingdom follows with a 14.6% CAGR, supported by a robust nutraceutical manufacturing base that aggressively sources novel joint-health ingredients.

Eggshell Membrane Powder Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 2 Billion
Industry Value (2036)	USD 7 Billion
CAGR (2026–2036)	13.1%

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research.

Why Is Clinical Validation Reshaping Procurement?

Nutraceutical brands are fundamentally altering their procurement criteria, moving away from generic specifications toward clinically backed branded ingredients that guarantee bioactive levels. Suppliers like Biova LLC have responded by launching updated formulations in August 2025 that promise minimum thresholds of collagen and elastin, directly addressing buyer demands for efficacy transparency.

This shift forces commodity egg protein producers to upgrade their processing capabilities or risk being relegated to low-margin animal feed channels. Consequently, the premium tier of the market is becoming an intellectual property battleground where value is captured by those holding robust clinical data rather than just processing capacity.

How is Europe’s Regulatory Environment Shaping the Adoption of Eggshell Membrane Powder?

Europe provides a critical blueprint for this trend, where regulatory pressure accelerates the adoption of upcycled ingredients in premium formulations. In 2024, Eurostat data estimated that 98.6 billion eggs were produced for consumption in the EU, representing a vast untapped reservoir for membrane extraction that remains underutilized compared to North American benchmarks.

This utilization gap drives immediate opportunities for technology providers who can retrofit existing European breaking plants with modular separation units, bypassing the need for greenfield construction. As egg powder processors adopt these systems, the regional market will likely see a surge in localized membrane supply, reducing reliance on imports and insulating European buyers from global freight volatility.

Institutional buyers and multinational formulators are simultaneously re-evaluating their supply chains to prioritize ingredients that offer verifiable carbon reduction stories. Companies procuring dried eggs or egg white protein powder are increasingly requesting lifecycle assessments that include membrane valorization as a scope 3 offset. Consequently, the commercial viability of egg products now depends heavily on the ability to market every component of the egg, pushing processors to diversify into eggshell membrane powder. This integration strategy not only improves margin blends for commodity producers but also secures long-term partnerships with cosmetic and nutraceutical brands seeking egg replacement ingredients that align with circular economy goals.

How Is the Eggshell Membrane Powder Market Segmented?

The eggshell membrane powder market is segmented by type, application, and nature, with value increasingly concentrating in high-purity formats that serve clinical nutraceuticals and sustainable cosmetics. By 2036, the industry outlook points toward a sharp bifurcation where functional "powdered" and "hydrolyzed" types capture the premium margin pool, while conventional byproduct streams feed bulk pet nutrition applications.

Within the nature segment, organic certification is emerging as a critical gatekeeper for entry into the European cosmetic sector, forcing suppliers to segregate supply chains early in the grading process. This structural segmentation means that while volume may sit in general food and beverage applications, the profit durability lies in specialized, clinically-backed ingredient grades.

Why Does Powdered Eggshell Membrane Dominate the Market?

The powdered eggshell membrane segment commands a dominant 52.0% market share, favored for its versatility in capsules and functional food blends. Manufacturers prioritize this format because it offers superior stability and handling compared to liquid concentrates, which is essential for global distribution logistics that require extended shelf life.

FMI analysts opine that this segment will maintain its lead as formulators in the egg albumin protein sector continue to bundle membrane powders into joint-health stacks for athletic recovery products. Innovation in milling technologies is further enhancing the solubility of these powders, expanding their application scope into ready-to-mix beverages. Recent corporate filings from Kewpie Corporation in 2024 highlight a strategic focus on expanding supply capacity for such high-value ingredients, confirming that powdered formats remain the primary vehicle for scaling export revenues.

Why Is the Nutraceutical Application Segment Growing Rapidly?

Nutraceutical applications account for 42.6% of total revenue, driven by an aging global population seeking natural remedies for osteoarthritis and joint stiffness. Recent research published in Bone Reports in May 2024 confirmed membrane efficacy for bone mineralization, providing the scientific validation needed to sustain high adoption rates among medical practitioners.

This clinical support allows brands to command higher price points compared to egg substitute ingredients used in standard food processing. As regulatory bodies scrutinize health claims more closely, this evidence-backed segment provides a safe harbor for investors looking for resilient growth. Furthermore, the shift toward preventive healthcare leads consumers to prioritize supplements with traceable origins, pushing manufacturers to source membranes from facilities that can provide complete chain-of-custody documentation from farm to capsule.

How Is Sustainability Driving Industrial Upcycling?

Environmental regulations regarding scope 3 emissions are compelling egg processors to adopt circular economy models that minimize landfill waste. Burnbrae Farms reported a 92% waste diversion rate in 2024, illustrating how leading players are successfully monetizing byproducts to meet sustainability targets while creating new revenue streams. This pressure is particularly acute for companies producing hydrolyzed egg products, where waste volumes are high and disposal costs are rising. By integrating membrane extraction, these operators transform a regulatory burden into a marketable asset, aligning with the sourcing policies of multinational cosmetic brands.

What Are the Regional Drivers for Eggshell Membrane Powder?

The regional growth outlook for the eggshell membrane powder market shows strong momentum led by Japan, which commands the highest CAGR of 18.9%, driven by stringent waste valorization regulations and rapid adoption of upcycled nutraceutical ingredients. The United Kingdom follows with a robust 14.6% CAGR as its advanced nutraceutical manufacturing ecosystem and supportive regulatory framework accelerate commercialization of functional ingredients.

Germany’s market is projected to grow at 8.5%, supported by rising consumer preference for organic and sustainably sourced inputs, while France, at 7.9%, benefits from deep integration with its luxury cosmetic industry that prioritizes bio‑active, traceable materials. The United States, with a 7.6% CAGR, continues to leverage its large-scale egg production base and expanding pet nutrition segment, reinforcing steady demand for membrane-derived functional proteins.

Country	CAGR (2026-2036)
Japan	18.9%
United Kingdom	14.6%
Germany	8.5%
France	7.9%
United States	7.6%

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research.

Why Japan Rewards Industrial Symbiosis In Nutraceuticals?

Sales of eggshell membrane powder in Japan are set to rise at 18.9% CAGR. A unique convergence of strict waste disposal laws and a high-density population drives intense innovation in byproduct valorization. Japan generates approximately 4.72 million tons of food loss and waste annually, forcing the Ministry of the Environment to impose rigorous recycling mandates on food manufacturers. This regulatory environment incentivizes companies like Kewpie to invest heavily in extraction technologies that maximize resource recovery from every egg processed.

Samurai Trading, President, Samurai Trading (Feb 2026) stated that: "If we don't commit to reducing emissions to the limit, there is no point in doing this business." This zero-waste philosophy is reshaping the entire supply chain, pushing processors to develop novel applications like bioplastics from shells. Consequently, Japanese suppliers are becoming global leaders in high-efficiency separation techniques that set the standard for the egg stabilizer sector.

How UK Manufacturers Utilize Novel Food Approvals?

Demand for eggshell membrane powder in the United Kingdom is anticipated to grow at 14.6% CAGR. Industry benefits from a sophisticated regulatory framework that encourages the rapid commercialization of novel functional ingredientsBritish nutraceutical brands leverage this local supply to produce clean-label supplements that appeal to health-conscious consumers.DEFRA statistics show that liquid egg production accounted for 78% of total output in Q2 2024, providing a consistent, high-volume source of fresh shells for immediate processing.

The decoupling from EU frameworks has allowed UK regulators to streamline approval processes for innovative health claims, attracting foreign investment into domestic egg powder facilities. The processing volume of 19 thousand tonnes of egg products in Q2 2024 alone suggests a robust feedstock baseline that supports continuous industrial-scale membrane extraction without seasonal supply shocks.

What Drives German Organic Ingredient Demand?

Eggshell membrane powder activity in Germany is projected to expand at 8.5% CAGR. German consumers exhibit a strong preference for organic and sustainably sourced products, influencing procurement strategies across the food and cosmetic sectors. Destatis reports that the share of organic eggs in Germany reached 14.1% in 2024, up from 13.4% the previous year, signaling a structural shift toward premium production methods. Manufacturers of sugared egg yolk are responding by segregating organic shells for specialized membrane extraction lines.

This segmentation allows German suppliers to command significant price premiums in the export market, particularly for certified organic membrane powders used in natural cosmetics. With 13.7 billion eggs produced by large-scale commercial facilities in 2024, the centralization of supply facilitates the implementation of high-efficiency membrane separation units directly at the breaking point.

Why France Focuses On Cosmetic Applications?

Eggshell membrane powder in France is poised to register a 7.9% CAGR. Industry is characterized by a deep integration between agricultural processing and the luxury cosmetic industry. Although egg production value decreased by 7.7% between 2023 and 2024 due to price corrections, volume remains sufficient to support a thriving upcycling ecosystem. Cosmetic giants in France actively seek bio-active ingredients like collagen from egg wash substitute byproducts to replace synthetic alternatives. Startup activity, exemplified by ventures like Circul'Egg, focuses on decentralizing processing to farm levels, thereby preserving ingredient freshness and bioactivity for high-end skincare formulations. This "farm-to-face" traceability is becoming a decisive purchasing factor for French luxury brands, which demand verifiable sustainability metrics to support their premium product claims.

How Is The USA Scaling Pet Nutrition Applications?

Eggshell membrane powder in the United States is poised to register a 7.6% CAGR. The US market is driven by the massive scale of its pet food industry, which increasingly utilizes membrane ingredients for canine joint health. With the average layer flock size totaling 377 million in October 2024, the US possesses an unrivaled raw material base for industrial-scale extraction. Major ingredient players like Stratum Nutrition use this volume to fuel aggressive expansion strategies, both domestically and abroad.

Stratum Nutrition, International Business Development, Stratum Nutrition (Aug 2025) noted: "With our expertise in navigating Europe's diverse business landscape, we see tremendous opportunities for Stratum to connect with local partners, address market needs, and contribute to the growth of the industry across the region." This export-oriented mindset allows US producers to balance domestic feed-grade demand with high-margin international sales, optimizing capacity utilization.

Why Is IP Consolidation Defining Market Leaders?

Incumbent players are actively fortifying their positions through aggressive intellectual property strategies and formulation updates that raise the bar for entry. Biova LLC’s 2025 launch of guaranteed collagen and elastin levels in their pet ingredients exemplifies how leaders use proprietary specs to differentiate from commodity breakers. FMI analysts opine that this "spec-flation" forces smaller competitors to license technology or exit the premium segment, effectively consolidating high-margin revenue among a few patent holders. By locking in key claims for joint health and skin elasticity, these leaders create high switching costs for brands using egg emulsifier byproducts in their formulations.

Startups in the industry are bypassing the traditional supply chain entirely by leveraging biotechnology to create identical proteins without the egg. Startups like Melt&Marble, having secured €7 million in Series A funding in late 2025, are pioneering precision fermentation to produce designer fats and structural proteins that mimic animal-derived ingredients. This technological leap presents a distinct long-term threat to traditional membrane suppliers, particularly in the vegan-friendly personal care sector. As these biotech firms scale from R&D to commercial production, they offer consistent, ethically unassailable alternatives that appeal to the same sustainability-minded buyers currently purchasing upcycled united states dried eggs derivatives.

Recent Developments

•  In January 2025, Stratum Nutrition launched Ovolux, a premium upcycled eggshell membrane collagen ingredient sourced from USDA eggshells, supported by a new clinical study demonstrating benefits for hair shine, skin hydration, and firmness. This innovation targets the beauty-from-within segment, offering a sustainable, bioactive alternative for nutraceutical and cosmetic formulations in the growing eggshell membrane powder market.
• In May 2025, IQI Trusted Petfood Ingredients partnered with Eggnovo to exclusively distribute Ovopet, a collagen-rich eggshell membrane powder, across North America for pet food applications. This agreement expands access to Ovopet’s proven joint, skin, and gut health benefits, enabling pet food manufacturers to incorporate natural, high-performance ingredients and driving growth in the animal nutrition segment.
• In August 2025, Stratum Nutrition's full eggshell membrane ingredient portfolio, including NEM and other derivatives, earned NutraStrong certification for quality, transparency, and claim substantiation. This third-party validation reinforces consumer trust in eggshell membrane powders for joint health and wellness supplements, differentiating Stratum's offerings in a competitive market focused on clean-label and evidence-based products.

Key players in Eggshell Membrane Powder Market

• Biova LLC
• Stratum Nutrition
• Eggnovo SL
• Ecovatec Solutions
• Kewpie Corporation
• Microcore Research Laboratories
• Eggbrane
• Certified Nutraceuticals Inc.
• Bolise Co., Limited
• Mitushi Biopharma

Market Definition

Eggshell membrane powder is defined as the bioactive material obtained from the separation, drying, and milling of the proteinaceous lining found between the egg white and the shell of poultry eggs. The market inclusion covers all forms of processed membrane, including hydrolyzed powder, unhydrolyzed (native) powder, and concentrated extracts utilized in dietary supplements, cosmetics, pet food, and functional beverages. It encompasses revenue generated from the sale of these ingredients by processors, ingredient manufacturers, and specialized breakers to end-use formulators and contract manufacturers.

The market explicitly excludes the sale of raw, unprocessed eggshells intended for low-value agricultural lime or simple calcium carbonate applications where the membrane has not been separated or valorized. It also excludes whole egg products where the shell and membrane are discarded as waste without further processing or revenue generation. FMI analysts opine that this distinction is crucial for accurately sizing the value-added ingredient sector versus the broader commodity waste stream.

Revenue from finished consumer products containing eggshell membrane (e.g., a bottle of joint health capsules) is excluded; the market size reflects only the B2B sales of the ingredient itself. Additionally, synthetic or fermentation-derived alternatives that mimic membrane proteins are excluded from the primary market sizing but are tracked as competitive technologies.

Scope of Report

Items	Values
Quantitative Units (2026)	USD 2 Billion
Type	Powdered Eggshell Membrane (52.0%), Concentrated Eggshell Membrane, Other Forms
Application	Nutraceutical (42.6%), Food & Beverages, Pet Food Industry, Cosmetic & Personal Care, Other Applications
Nature	Organic (57.3%), Conventional
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Countries covered	Japan, United Kingdom, Germany, France, United States
Key companies profiled	Biova LLC, Stratum Nutrition, Eggnovo SL, Ecovatec Solutions, Kewpie Corporation
Additional attributes	Revenue analysis by segments, adoption trends across settings, regulatory and compliance landscape (as relevant), pricing and reimbursement considerations (when relevant), channel mix economics, supply chain exposure, and competitive positioning analysis

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research.

Key Segments

By Type

• Powdered Eggshell Membrane
• Concentrated Eggshell Membrane
• Other Forms

By Application

• Nutraceutical

• Food & Beverages
• Pet Food Industry
• Cosmetic & Personal Care
• Other Applications

By Nature

• Organic
• Conventional

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Bibliography

• USDA National Agricultural Statistics Service (NASS). (2024). Chickens and Eggs Report October 2024. United States Department of Agriculture.
• Eurostat. (2024). Poultry statistics: Annual production of eggs for consumption. European Commission.
• Department for Environment, Food & Rural Affairs (DEFRA). (2024). United Kingdom Egg Statistics Quarter 2 2024. Government of the United Kingdom.
• Ministry of the Environment (MOE). (2024). Food Loss and Waste Generation in Japan FY2022. Government of Japan.
• Federal Statistical Office (Destatis). (2024). Animals and Animal Production Statistics 2024. Government of Germany.
• Agreste - DRAAF Bretagne. (2025). Conjoncture Volailles de ponte 2024. Ministry of Agriculture and Food Sovereignty, France.